TG Therapeutics Inc

Stock Chart, Company Information, and Scan Results

$31.51(as of Mar 17, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

TG Therapeutics Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$31.51
Ticker SymbolTGTX
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees399
CountyUSA
Market Cap$4,594.2M
EBIDTA123.4M
10-Day Moving Average28.92
P/E Ratio11.23
20-Day Moving Average29.37
Forward P/E Ratio23.09
50-Day Moving Average29.54
Earnings per Share2.77
200-Day Moving Average32.41
Profit Margin11.96%
RSI61.30
Shares Outstanding159.7M
ATR1.37
52-Week High46.48
Volume4,037,190
52-Week Low25.28
Most Recent Support Level26.76
Book Value648.0M
Most Recent Resistance Level29.54
P/B Ratio7.75
Upper Keltner32.46
P/S Ratio8.15
Lower Keltner26.28
Debt-to-Equity Ratio32.46
Next Earnings DateUnknown
Cash Surplus-74.6M
Next Ex-Dividend DateUnknown

TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally. The company provides BRIUMVI, an anti-CD20 monoclonal antibody for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults. The company's development pipeline comprises Ublituximab IV, glycoengineered anti-CD20 mAb for the treatment of relapsing MS; TG-1701 is an orally available and covalently bound Bruton's tyrosine kinase (BTK) inhibitor that exhibits selectivity to BTK in vitro kinase screening; and TG-1801, a bispecific CD47 and CD19 antibody. Its research pipeline includes various investigational medicines. The company has license agreements with LFB Biotechnologies S.A.S; GTC Biotherapeutics; LFB/GTC LLC; Ildong Pharmaceutical Co. Ltd.; and Jiangsu Hengrui Medicine Co. The company was incorporated in 1993 and is based in Morrisville, North Carolina.

TG Therapeutics Inc In Our Stock Scanner

As of Mar 18, 2026
example chart graphic
Scan Name: Momentum StocksScan Type: Stock Indicator Scans
As of ---
example chart graphic
Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.